Palonosetron hydrochloride

Details

Files

Generic Name:

Project Status:

Complete

Therapeutic Area:

Chemotherapy-induced nausea and vomiting

Manufacturer:

Eisai Ltd.

Call for patient/clinician input open:

October 5, 2012

Brand Name:

Aloxi (injection)

Project Line:

Reimbursement Review

Project Number:

SR0293-000

Call for patient/clinician input closed:

October 26, 2012

NOC Status at Filing:

Post NOC

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Nausea and vomiting (chemotherapy induced) prevention

Recommendation Type:

Do not list at the submitted price

Final Recommendation:

May 15, 2013

Last Updated : October 5, 2012